Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SYY vs GSK✓SelectedUSD · GSKSYY vs GSK performance historyLatest closeAs of+1.32%11/20
Stock and ETF performance explorer

SYY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+19.1%
GSK return
+53.4%
Excess return
-34.2%
Maximum drawdown
-24.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%-0.1%+1.4%+1.3%
7D+1.4%-5.3%+6.7%+2.6%
30D-4.7%-3.7%-1.1%-4.0%
3M-5.2%-7.3%+2.0%-3.8%
6M+5.0%-4.2%+9.3%+5.8%
YTD+9.2%+0.9%+8.3%+8.6%
1Y+6.6%+7.3%-0.7%+4.8%
3Y+19.1%+52.7%-33.6%+6.2%
All+19.1%+53.4%-34.2%+6.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling